CSL Limited

ASX:CSL.AX

Sector

🏥 Health Care

Industries

🧬 Biotechnology

💊 Pharmaceuticals

💉 Vaccines

Location

Australia

Market Cap

USD 85.23 B

Share Price

USD 176.07

Avg Daily Volume

786,869

Change (1 day)

0.95%

Change (1 year)

-13.10%

Change (YTD)

1.03%

CSL Limited EBITDA for the year ending June 30, 2024: USD 4.73 B

CSL Limited EBITDA is USD 4.73 B for the year ending June 30, 2024, a -19.16% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

CSL Limited EBITDA for the year ending June 30, 2023 was USD 5.85 B, a 68.97% change year over year.
CSL Limited EBITDA for the year ending June 30, 2022 was USD 3.46 B, a 27.16% change year over year.
CSL Limited EBITDA for the year ending June 30, 2021 was USD 2.72 B, a 25.10% change year over year.
CSL Limited EBITDA for the year ending June 30, 2020 was USD 2.18 B, a 7.69% change year over year.